Brian Britson not only took over the lead position at Amgen Rhode Island in the midst of the COVID-19 pandemic in August 2020, but the multinational biopharmaceutical company was in the middle of building a 120,000-foot-square “next-generation” biomanufacturing factory on its West Greenwich campus. Talk about a high level of difficulty. But it appears Britson…
You must be a paid subscriber to read this content.
To keep reading and receive unlimited access subscribe today for only $1.
Subscribe NowAlready a Subscriber?
Login now
Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.